Treating age-related diseases with somatic stem cells

Robert W. Brooks, Paul D Robbins

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Life expectancy in the developed world has advanced beyond the number of years in which healthy tissue homeostasis can be maintained, and as a result, the number of persons with severe and debilitating chronic illnesses, including cancer, diabetes, osteoarthritis, osteoporosis, neurodegenerative and cardiovascular disease has continued to rise. One of the key underlying causes for the loss in the ability to replenish damaged tissues is the qualitative and quantitative decline in somatic stem cell populations. A concerted effort to understand why aging adult stem cells fail to maintain “stem” potential while simultaneously developing new strategies and therapeutic interventions to prevent or reverse age-dependent stem cell decline is required to improve the overall healthspan of our rapidly aging population. This review focuses on what drives stem cell dysfunction with age, the contribution of stem cell dysfunction in driving aging and therapeutic approaches using stem cells to treat aging.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages29-45
Number of pages17
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Publication series

NameAdvances in Experimental Medicine and Biology
Volume1056
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Fingerprint

Adult Stem Cells
Stem cells
Stem Cells
Aging of materials
Tissue homeostasis
Life Expectancy
Osteoarthritis
Neurodegenerative Diseases
Population
Osteoporosis
Homeostasis
Chronic Disease
Cardiovascular Diseases
Medical problems
Therapeutics
Tissue
Neoplasms

Keywords

  • Aging
  • Mesenchymal stem cells
  • Senescence
  • Senolytics
  • Stem cells

PubMed: MeSH publication types

  • Journal Article
  • Review

Cite this

Brooks, R. W., & Robbins, P. D. (2018). Treating age-related diseases with somatic stem cells. In Advances in Experimental Medicine and Biology (pp. 29-45). (Advances in Experimental Medicine and Biology; Vol. 1056). Springer New York LLC. https://doi.org/10.1007/978-3-319-74470-4_3

Treating age-related diseases with somatic stem cells. / Brooks, Robert W.; Robbins, Paul D.

Advances in Experimental Medicine and Biology. Springer New York LLC, 2018. p. 29-45 (Advances in Experimental Medicine and Biology; Vol. 1056).

Research output: Chapter in Book/Report/Conference proceedingChapter

Brooks, RW & Robbins, PD 2018, Treating age-related diseases with somatic stem cells. in Advances in Experimental Medicine and Biology. Advances in Experimental Medicine and Biology, vol. 1056, Springer New York LLC, pp. 29-45. https://doi.org/10.1007/978-3-319-74470-4_3
Brooks RW, Robbins PD. Treating age-related diseases with somatic stem cells. In Advances in Experimental Medicine and Biology. Springer New York LLC. 2018. p. 29-45. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-3-319-74470-4_3
Brooks, Robert W. ; Robbins, Paul D. / Treating age-related diseases with somatic stem cells. Advances in Experimental Medicine and Biology. Springer New York LLC, 2018. pp. 29-45 (Advances in Experimental Medicine and Biology).
@inbook{f9e6cf5474bb4a0a89c51b52617caab0,
title = "Treating age-related diseases with somatic stem cells",
abstract = "Life expectancy in the developed world has advanced beyond the number of years in which healthy tissue homeostasis can be maintained, and as a result, the number of persons with severe and debilitating chronic illnesses, including cancer, diabetes, osteoarthritis, osteoporosis, neurodegenerative and cardiovascular disease has continued to rise. One of the key underlying causes for the loss in the ability to replenish damaged tissues is the qualitative and quantitative decline in somatic stem cell populations. A concerted effort to understand why aging adult stem cells fail to maintain “stem” potential while simultaneously developing new strategies and therapeutic interventions to prevent or reverse age-dependent stem cell decline is required to improve the overall healthspan of our rapidly aging population. This review focuses on what drives stem cell dysfunction with age, the contribution of stem cell dysfunction in driving aging and therapeutic approaches using stem cells to treat aging.",
keywords = "Aging, Mesenchymal stem cells, Senescence, Senolytics, Stem cells",
author = "Brooks, {Robert W.} and Robbins, {Paul D}",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-3-319-74470-4_3",
language = "English (US)",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "29--45",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Treating age-related diseases with somatic stem cells

AU - Brooks, Robert W.

AU - Robbins, Paul D

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Life expectancy in the developed world has advanced beyond the number of years in which healthy tissue homeostasis can be maintained, and as a result, the number of persons with severe and debilitating chronic illnesses, including cancer, diabetes, osteoarthritis, osteoporosis, neurodegenerative and cardiovascular disease has continued to rise. One of the key underlying causes for the loss in the ability to replenish damaged tissues is the qualitative and quantitative decline in somatic stem cell populations. A concerted effort to understand why aging adult stem cells fail to maintain “stem” potential while simultaneously developing new strategies and therapeutic interventions to prevent or reverse age-dependent stem cell decline is required to improve the overall healthspan of our rapidly aging population. This review focuses on what drives stem cell dysfunction with age, the contribution of stem cell dysfunction in driving aging and therapeutic approaches using stem cells to treat aging.

AB - Life expectancy in the developed world has advanced beyond the number of years in which healthy tissue homeostasis can be maintained, and as a result, the number of persons with severe and debilitating chronic illnesses, including cancer, diabetes, osteoarthritis, osteoporosis, neurodegenerative and cardiovascular disease has continued to rise. One of the key underlying causes for the loss in the ability to replenish damaged tissues is the qualitative and quantitative decline in somatic stem cell populations. A concerted effort to understand why aging adult stem cells fail to maintain “stem” potential while simultaneously developing new strategies and therapeutic interventions to prevent or reverse age-dependent stem cell decline is required to improve the overall healthspan of our rapidly aging population. This review focuses on what drives stem cell dysfunction with age, the contribution of stem cell dysfunction in driving aging and therapeutic approaches using stem cells to treat aging.

KW - Aging

KW - Mesenchymal stem cells

KW - Senescence

KW - Senolytics

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=85047086667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047086667&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-74470-4_3

DO - 10.1007/978-3-319-74470-4_3

M3 - Chapter

C2 - 29754173

AN - SCOPUS:85047086667

T3 - Advances in Experimental Medicine and Biology

SP - 29

EP - 45

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -